Furthermore, multivariate analysis using the Cox proportional hazards model indicated that the PHF2 and C/EBPα expression levels were an independent predictor of cancer-specific and progression-free survival in patients with ccRCC when assessed by the WHO/ISUP grade and pTNM stage (Table 2). The gene discussed is PHF2; the disease is cancer.